Sociedad Americana de Hirudoterapia

Coccydynia (Chronic)

Investigational use for chronic coccyx pain after fall, childbirth, or idiopathic onset; small case series for refractory cases.

Tier C — InvestigationalInvestigacionalLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Resumen para el Paciente

¿Está esto autorizado por FDA para este uso?
Not FDA-cleared for coccydynia. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
¿Qué evidencia existe?
Tier C (investigational). There are no published controlled trials. Evidence-based care for coccydynia: cushioned wedge-shaped or donut seating to off-load the coccyx, NSAIDs, manual therapy (intrarectal coccyx manipulation has modest RCT support), pelvic floor physical therapy, and (refractory) image-guided ganglion impar block or coccyx injection. Surgical coccygectomy is reserved for truly refractory cases. Most coccydynia from minor trauma or childbirth resolves over months to a year with conservative care.
Riesgos principales
  • Bleeding from each bite site for 6 to 24 hours after detachment
  • Bruising over the sacrococcygeal region for 5 to 10 days
  • Local skin or, rarely, Aeromonas hydrophila infection - the sacrococcygeal region has fecal contamination risk
  • Allergic reaction to leech saliva (uncommon)
  • Worsening coccyx pain from local irritation
  • Risk of bite-site irritation from sitting pressure (this area is constantly pressured)
  • Delay of cushion support, manual therapy, and image-guided injection
Quién no debería considerar esto
  • Patients with red-flag features (fever, weight loss, night pain, cancer history) - imaging needed first
  • Patients with recent significant trauma needing imaging to rule out coccyx fracture
  • Patients with pelvic floor dysfunction who need pelvic floor physical therapy first
  • Patients with hemorrhoids, anal fissure, or perianal abscess (alternate diagnosis)
  • Patients who have not tried cushioned seating, manual therapy, and adequate conservative care
  • Patients on anticoagulants, with hemophilia, or with severe anemia
  • Patients with active dermatitis or broken skin over the sacrococcygeal region
Qué preguntar a su clínico
  • Have we ruled out coccyx fracture, sacrococcygeal tumor, or referred pain from other pelvic pathology?
  • Have I tried cushioned wedge or donut seating, NSAIDs, and manual therapy?
  • Have I tried pelvic floor physical therapy?
  • Am I a candidate for image-guided ganglion impar block or coccyx injection?
  • Where exactly will leeches be placed - confirm placement avoids the perianal region and any fecal contamination zone?
  • What is the Aeromonas-prevention protocol given the contamination risk in this area?
  • What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
Cuándo buscar atención urgente
  • Bowel or bladder dysfunction, saddle anesthesia, or bilateral leg weakness (cauda equina - 911)
  • Fever, severe pelvic pain, or perianal swelling (possible deep infection or abscess)
  • Sudden severe pain after a fall or trauma
  • Blood in the stool or rectal bleeding
  • Bleeding from a bite site lasting more than 24 hours
  • Spreading redness, pus, or warmth at the bite site
  • Hives, facial or throat swelling, or breathing difficulty

Qué NO significa esto

  • This is not FDA-cleared for coccydynia.
  • No controlled trials support efficacy.
  • It does not replace cushioned seating, manual therapy, or image-guided ganglion impar block - which have stronger evidence.
  • The sacrococcygeal region has higher infection risk because of proximity to fecal contamination.
  • Most coccydynia resolves with conservative care over months; procedural intervention is rarely needed early.

Clinical Profile

Category
musculoskeletal
ICD-10
M53.3
Safety tier
medium

Evidence Summary

Chronic coccydynia is conventionally managed with seating modification, NSAIDs, manual coccygeal manipulation, and image-guided corticosteroid injection. Coccygectomy is reserved for refractory cases (>6 months of conservative failure). Imaging (dynamic radiographs, MRI) should differentiate hypermobility, fracture, or chordoma. No controlled clinical trial or published case series of leech therapy for coccydynia has been reported; any use is investigational and mechanistic only. If leech therapy were ever considered, it would be placed on healthy skin lateral to the coccyx and never on the perianal midline.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Khan IA et al. (2021), n=18

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Active perianal abscess, fissure, or fistula
  • Coccyx fracture or chordoma
  • Pregnancy

Related Conditions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.

Coccydynia (Chronic) — Hirudotherapy Evidence | ASH